Sleep Misinformation Versus the ‘Sleepfluencers’
Rather than ceding social media to unqualified influencers, sleep medicine professionals are learning to compete for public attention with evidence-based education.
Rather than ceding social media to unqualified influencers, sleep medicine professionals are learning to compete for public attention with evidence-based education.
Resmed will acquire the manufacturer of an FDA-cleared nerve stimulation device for refractory RLS, a move that leverages its existing sleep physician and home medical equipment channels.
It will launch in early 2026 in a limited US beta version.
Resmed’s Mick Farrell, new AdvaMed chair, outlines strategic priorities for the trade organization.
Read MoreStudy forecasts nearly 77 million US adults will have obstructive sleep apnea by 2050, with women experiencing the sharpest rise.
Read MoreThe acquisition aims to simplify and accelerate the patient journey from initial evaluation to treatment, reducing patient drop-off and improving access to care.
Read MoreResmed has completed scaling up the availability of NightOwl, its FDA-cleared fingertip home sleep test acquired from Ectosense, now making the simplified, disposable OSA diagnostic device broadly accessible across the US market.
Read MoreWhether CPAP makes a difference in long-term outcomes for people with OSA has been hotly debated.
Read MoreResmed’s brand evolution ‘is more than a new look—it’s a bold step forward in our strategy to make sleep and breathing health a mainstream priority in global healthcare.’
Read MoreThe fifth annual Global Sleep Survey by ResMed reports on the gap between sleep difficulties and taking action to fix them, workplace productivity impacts of lost sleep, sleep’s impact on relationships, and sex differences in sleep.
Read MoreIt also names one for research use only and does not make a determination on a device that is awaiting CE approval.
Read MoreWhy and how the year 2025 could mark the start to an era of innovation for unattended sleep testing.
Read MoreRemote CPAP setup solutions are changing how patients access care—but are they as effective as in-person setups?
Read MoreResMed attributes revenue growth to strong demand for sleep apnea products, as well as gross across its residential care software business.
Read MoreResMed sets its sights on long-term growth with a newly unveiled 2030 vision.
Read MoreThe company is also introducing a generative AI-enabled sleep health assistant to guide people on their journey to better sleep and new travel gear to help people stay on CPAP treatment while traveling.
Read MoreThe nasal mask, featuring a fabric-wrapped frame in a tube-up design, will be available in the US in late October.
Read More